Partial hydatidiform mole evolving into metastatic trophoblastic tumor: case report

Partial hydatidiform mole can evolve into a metastatic trophoblastic tumor. A 36-year-old, multiparous woman, pregnant with a 22-week embryonic hydatidiform mole, having spontaneously expelled. Histopathological examination showed a non-invasive partial mole. During biological monitoring, a trophoblastic tumor was diagnosed with pulmonary metastasis on CT-scan and myometrial invasion by MRI. Authors opted for a monochemotherapy with a good evolution. The potential risk of malignant transformation of the partial hydatidiform mole requires an adequate therapeutic strategy with strict monitoring.

Differential expression of cyclin E, p63, and Ki-67 in gestational trophoblastic disease and its role in diagnosis and management: A prospective case–control study

Background: Gestational trophoblastic disease (GTD) constitutes a spectrum of tumors and tumor-like conditions, characterized by proliferation of pregnancy-associated trophoblastic tissue of progressive malignant potential. It is very difficult to differentiate these complex groups of lesions basing on histomorphology alone. Immunohistochemistry (IHC) with cyclin E, P63, and Ki-67 has a definite role in the identification of different trophoblasts and entities of GTD and also in the determination of biological behavior. Aims: The aim of this study is to find the differential expression of cyclin E, p63, and Ki-67 in normal placenta, hydropic abortus (HA), and various entities of GTD. Design and Settings: A prospective case–control study conducted in a government medical college. Methods: Total 96 cases, divided into Group A (48 histologically confirmed cases of GTD) and Group B (controls comprising 8 HA and 40 normal placentas of different trimesters), were studied. The histological samples were subjected to IHC using cyclin E, Ki-67, and p63. Statistical Analysis: Results were analyzed using SPSS statistical method. Results: Among the three immunomarkers used, Cyclin E and Ki-67 show statistically significant difference (P < 0.05) when compared between GTD and control groups, but it was insignificant for p63 (P = 0.369). Strong staining intensity of cyclin E and Ki-67 is seen in complete moles, choriocarcinoma, and placental site trophoblastic tumor. Conclusion: This study was done to evaluate the role of cell cycle regulatory proteins such as cyclin E and p63 and proliferation marker Ki-67 in the detection of various trophoblasts and differential diagnosis of the lesions associated with them.

Inter-observer variability in the histologic criteria of diagnosis of hydatidiform moles

@#Introduction: In the event of encountering hydropic villi in products of conception specimens, pathologists will have to distinguish complete and partial hydatidiform mole (CHM & PHM) from hydropic abortion (HA). The histological diagnostic criteria are subjective and demonstrate considerable inter-observer variability. Materials and Methods: This study evaluated the inter-observer variability in diagnosis of CHM, PHM and HA according to defined histologic criteria. Ninety abortus conception specimens were reviewed. Representative haematoxylin and eosin-stained slides were assigned independently to two pathologists who were asked to make a diagnosis of CHM, PHM or HA, and provide a report of the identified diagnostic histological criteria. Kappa value was calculated for the inter-observer agreement. Results: There was a total of 36.7% disagreement between two pathologists (K = 0.403, Strength of Agreement = moderate), of which 24.4% and 12.2%, were differentiating PHM from CHM and PHM from HA, respectively. Among defined diagnostic histological criteria, the highest rate of agreement was observed in the identification of cistern formation and hydropic changes (K = 0.746 and 0.686 respectively, Strength of Agreement = substantial). Conclusion: There was moderate to substantial agreement rate between two pathologists in identification of two essential histologic criteria for diagnosis of molar pregnancies i.e. “hydropic change” and “trophoblastic proliferation”.

Mola hidatiforme parcial del segundo trimestre / Second trimester partial hydatidiform mole

La mola hidatiforme coexistente con un feto vivo es una entidad infrecuente que se caracteriza por la degeneración hidrópica de las vellosidades coriales, hiperplasia del trofoblasto y evidencia macroscópica de un feto. El objetivo del trabajo fue describir el caso clínico de una paciente con diagnóstico de mola parcial y edad gestacional de 23 semanas. Presentamos una paciente de 31 años remitida de consulta de perinatología con 22,5 semanas de gestación, tensión arterial elevada, signo de más y ecografía con 20 semanas que describe placenta con lagos venosos; con antecedentes de alfafetoproteína elevada. En el hospital empeoró su estado con una preeclampsia agravada, y con ecografía evolutiva que describe placenta de 71 mm, con múltiples lagos venosos. Se plantea posible enfermedad trofoblástica y se discute para interrupción del embarazo. Se realizó microcesárea, se obtiene feto muerto femenino de 600 gramos, con placenta de 400 gramos con múltiples vesículas que recuerdan la mola parcial, diagnóstico que se confirma posteriormente con estudio histopatológico. En la mola parcial, el embrión rara vez sobrevive hasta el segundo trimestre. Si no se realizan pruebas citogenéticas, posiblemente no se diagnostiquen porque los cambios histológicos suelen ser sutiles. La clínica, la fracción beta de la gonadotropina coriónica y el estudio de la placenta, el feto o ambos, son los que permitirán realizar el diagnóstico definitivo para determinar el seguimiento y disminuir las complicaciones(AU)

The hydatidiform mole coexisting with a living fetus is a rare entity that is characterized by hydropic degeneration of the chorionic villi, hyperplasia of the trophoblast and macroscopic evidence of a fetus. The objective of the study was to describe the clinical case of a patient with a diagnosis of partial mole and gestational age of 23 weeks. We present a 31-year-old patient referred for perinatology consultation with 22.5 weeks of gestation, high blood pressure, plus sign and ultrasound with 20 weeks describing placenta with venous lakes; and history of high alpha-fetoprotein. In the hospital, her condition worsened with aggravated preeclampsia, and with an evolving ultrasound, that describes a 71 mm placenta with multiple venous lakes. Possible trophoblastic disease arises and is discussed for termination of pregnancy. Micro-cesarean surgery was performed, a female fetus weighing 600 grams was obtained, a placenta of 400 grams with multiple vesicles that resemble partial mole. This diagnosis is later confirmed with histopathological study. In partial mole, the embryo rarely survives until the second trimester. If cytogenetic tests are not performed, they may not be diagnosed because the histological changes are usually subtle. The clinic, the beta fraction of the chorionic gonadotropin and the study of the placenta, the fetus or both, are the ones that will make the definitive diagnosis to determine the follow-up and decrease the complications(AU)

The significance of the expression of p57, CD34 and Ki-67 in edematous lesions of placental villi / 新乡医学院学报

Objective To observe the expression of p57,CD34 and Ki-67 in complete hydatidiform mole (CHM),partial hydatidiform mole (PHM) and hydropic abortus (HA),so as to investigate the role of the expression in the diagnosis and differential diagnosis of edematous lesions of placental villi.Methods A total of 45 cases of CHM tissue,40 cases of PHM tissue,28 cases of HA tissue and 22 cases of normal pregnancy tissue were collected from January 2003 to December 2013 in Anqiu People's Hospital.The expression of p57,CD34 and Ki-67 in placental villi were detected by immunohistochemistry.Results The positive expression rate of p57 in CHM,PHM,HA and normal pregnancy tissues was 2.22％ (3/45),85.00％ (34/40),89.29％ (25/28) and 95.45 ％ (21/22),respectively;the positive expression rate of p57 in CHM tissues was significantly lower than that in PHM,HA and normal pregnancy tissues (x2 =59.908,57.055,58.238;P ＜ 0.01);there was no significant difference in the positive expression rate of p57 in PHM,HA and normal pregnancy tissues (x2 =0.022,0.681,0.074;P ＞0.05).The expression of CD34 in CHM,PHM,HA and normal pregnancy tissues was 10.27 ± 3.00,11.13 ±2.58,35.57 ± 2.36 and 35.55 ± 2.22 respectively;the expression of CD34 in CHM and PHM tissues was significantly lower than that in HA and normal pregnancy tissues (t =37.89,37.86,39.79,37.40;P ＜ 0.01).There was no significant difference in the expression of CD34 between HA and normal pregnancy tissues (t =1.485,P ＞ 0.05),and there was no significant difference in the expression of CD34 between CHM and PHM tissues (t =1.404,P ＞ 0.05).The positive expression rate of Ki-67 in CHM,PHM,HA and normal pregnancy tissues was 64.44％ (29/45),55.00％ (22/40),14.29％ (4/28) and 9.09％ (2/22) respectively;the positive expression rate of Ki-67 in CHM and PHM tissues was significantly higher than that in HA and normal pregnancy tissues (x2 =18.21,12.61,17.53,11.56;P ＜ 0.01);there was no significant difference in the positive expression rate of Ki-67 between HA and normal pregnant tissues (x2 =0.015,P ＞ 0.05),and there was no significant difference in the positive expression rate of Ki-67 between CHM and PHM tissues (x2 =0.787,P ＞ 0.05).Conclusion p57 helps to identify CHM and other edematous lesions of placental villi,CD34 and Ki-67 help to identify hydatidiform mole and HA.Combined detection of p57,CD34 and Ki-67 is helpful for differential diagnosis of CHM,PHM and HA.

Placental mesenchymal dysplasia: A report of two cases with review of literature.

Placental mesenchymal dysplasia (PMD) is a recently recognized, rare placental vascular anomaly characterized by placentomegaly and grape-like vesicles mimicking partial molar pregnancy. It is associated with significant fetal morbidity and mortality. We describe the histologic features of PMD in two different cases with different disease outcomes, one in a preterm intrauterine death (IUD) and another in a live birth. Placental examination in both the cases revealed large placenta with multiple vesicles and mesenchymal dysplasia.

Mola hidatiforme parcial / Partial hydatidiform mole

Introducción: el término enfermedad trofoblástica gestacional es una anormal proliferación del trofoblasto, que desde el punto de vista histológico se clasifica en mola hidatiforme, mola invasora, coriocarcinoma y tumor del sitio de implantación del trofoblasto. Objetivo: describir las características clínicas y ultrasonográficas de una mola hidatiforme parcial o mola embrionada. Paciente: se presenta un caso de 24 sem de gestación con el diagnóstico ultrasonográfico de mola hidatidiforme parcial. Resultados: se realizó cariotipo fetal y determinación de niveles de gonadotropina coriónica en suero materno. Se hallaron defectos congénitos en el feto, por lo que se ofreció asesoramiento genético a la pareja, que optó por la interrupción de la gestación. Conclusiones: el diagnóstico prenatal fue confirmado por la anatomía patológica

Introduction: the term gestational trophoblastic disease is an abnormal proliferation of the trophoblast, which is histologically classified as hydatidiform mole, invasive mole, choriocarcinoma, and tumor trophoblast implantation site. Objective: to describe the clinical and ultrasonographic partial hydatidiform mole or mole embrionada. Patient: we report a 24- week - prenancy case with ultrasonographic diagnosis of partial hydatidiform mole. Results: fetal karyotype was performed and levels of chorionic gonadotropin in maternal serum were determined. We found congenital defects in the fetus, so genetic counseling was offered to the parents, who chose ending this pregnancy. Conclusions: the prenatal diagnosis was confirmed by pathology

Coexistencia demmola hidatiforme parcial con feto vivo de termino / Hydatidiform mole coexisting live fetus partial term

Se describe el caso clínico de una paciente de 31 años de edad, natural de Oruro, tercigesta, con antecedente de cesárea previa, sin otro antecedente personal ni familiar, de importancia, con gestación de 37 semanas, ruptura prematura de membranas, a quien se le realiza cesárea, obteniéndose un recién nacido vivo, de sexo masculino, de término, con peso de 2550 gr y APGAR de 8 y 10. La placenta pesó 1266 gr; en ella se observa una zona, con múltiples estructuras vesiculares, en forma de "racimos de uva", con contenido citrino al corte, compatible con mola hidatiforme parcial, diagnóstico que se confirma posteriormente con estudio histopatológico. La evolución de la paciente fue satisfactoria cursando su puerperio quirúrgico en forma favorable, por lo que se le indica su alta médica, realizándose por consulta externa seguimiento y monitorización hormonal (HCG cuantitativa) por enfermedad trofoblástica gestacional, sin datos clínicos o bioquímicos de persistencia o recurrencia. Se revisó aspectos de su baja frecuencia, etiología, diagnóstico y conducta.

A clinical case is described of a 31-year-old native of Oruro, coursing her third pregnaney, history of previous cesarean, no other personal nor family history of clinical relevance, with a 37-week gestation, premature rupture of membranes; therefore, Caesarean section was performed, resulting in a live newborn, male, term with 2550 gr and APGAR of 8 and 10. The placenta weighed 1266 gr. macroscopically it showed an área with múltiple vesicular structures, in the form of grapes, citrine content upon cut, compatible with partial hydatidiform mole. This diagnosis was subsequently confirmed histopathologically. The evolution of the patient was satisfactory, completing her surgical postpartum favorably, according to her discharge, conducted by outpatient follow-up and hormonal monitoring (quantitative HCG) for gestational trophoblastic disease without clinical or biochemical persistence or recurrence. We reviewed aspeets of its low frequeney, etiology, diagnosis, and behavior.

Twin pregnancy with diploid partial hydatidiform mole and coexisting fetuses following in vitro fertilization and embryo transfer: A case report / 대한산부인과학회지

A 24-year-old woman, gravida 1, para 0, was referred to our hospital at 14 weeks of gestation due to suspected twin pregnancy with hydatidiform mole and coexisting fetuses. The present pregnancy was achieved following in vitro fertilization and embryo transfer (IVF-ET). Ultrasound examinations at 14 weeks 3 days of gestation revealed a live fetus appropriate for assigned gestational age with a normal-looking placenta and a dead fetus with an additional echogenic mass resembling molar placenta. The patient was planned to take amniocentesis for chromosomal analysis. However, regular uterine contraction was developed and spontaneous expulsion was occurred at 14 weeks 4 days of gestation. Chromosomal analysis of twin pregnancy using normal and molar placental tissues revealed normal karyotype with 46,XY, 46,XX, respectively. Follow-up showed no progression to persistent gestational trophoblastic disease. We present a twin pregnancy with diploid partial hydatidiform mole and coexisting fetuses that occurred following IVF-ET, which was aborted spontaneously.

A Case of Persistent Metastatic Gestational Trophoblastic Disease after Partial Hydatidiform Mole / 대한산부인과학회지

Persistent tumor, usually non-metastatic, develops in approximately 4% of patients with a partial mole, and chemotherapy is required to achieve remission. Following evacuation of hydatidiform mole, careful hCG monitoring is mandatory since it is the most reliable and sensitive method for the early detection of gestational trophoblastic disease. In carefully selected patients in whom the risk of developing gestational trophoblastic disease is significant or when the availability of hCG testing is suboptimal, chemoprophylaxis has been shown to decrease the risk of gestational trophoblastic tumor. We report here a case of patient, 23- year-old woman who experienced unusual course after the evacuation of a partial mole and markedly elevated serum beta-hCG levels. The patient developed persistent metastatic gestational trophoblastic disease and was successfully treated with 3 courses of EMA-CO.

A Case of Partial Hydatidiform Mole with a Coexistent Live Fetus / 대한산부인과학회잡지

Hydatidiform moles are generally separated into two classifications. Complete hydatidiform moles are characterized by cystic swelling of all villi, often pronounced diffuse trophoblastic hyperplasia, lack of fetal parts, all 46 chromosomes of paternal origin (androgenesis). Partial hydatidiform moles appear to be focal trophoblastic hyperplasia, a fetus or indications of previous fetal existence, 69 chromosomes. Hydatidiform mole with coexistent fetus is a very rare phenomenon, with an estimated incidence of 0.005 to 0.01 percent of all pregnancies and associated with a risk of persistent gestational trophoblastic tumor. Recently, hydatidiform moles with a fetus have become more common due to use of assisted reproductive technology. Most patients with hydatidiform mole and coexisting normal fetus must cautioned about the potential for risks of malignant change and severe medical complications, such as preeclampsia, hyperthyroidism and antepartum hemorrhage, that may necessitate prompt pregnancy termination. We experienced a case of partial hydatidiform mole with coexistent live fetus, which was diagnosed by ultrasonography at 15 gestational weeks. A brief reviews of related literature was done.

A Case Report of Arteriovenous Malformation of the Uterus complicated with Hydatidiform Mole / 대한산부인과학회잡지

Uterine arteriovenous malformation(AVM) is a rare cause of massive uterine bleeding. Although uterine AVM is a rare cause of menorrhagia or postmenopausal bleeding, it is important to consider in the assessment of a patient with abnormal uterine bleeding because accurate diagnosis can allow appropriate treatment to be planned and avoid hysterectomy in women who wish to retain their reproductive capacity. Curettage may precipitate life-threatening hemorrhage and is therefore contraindicated when uterine AVM is suspected. These lesinons may be congenital or acquired. Acquired lesions are believed to follow trauma or may arise after choriocarcinoma or other gynecologic malignancies. Until rescently, this condition was difficult to diagnose and management almost always required hysterectomy. Doppler flow ultrasound and pelvic angiography are important for diagnosis and assessment. Transcatheter embolization has replaced hysterectomy as the treatment of choice in woman who wish to retain their fertility. We have experienced one case of uterine AVM complicated by partial hydatidiform mole, which is presented with a brief review of the literature.

Comparative Cytogenetic and Clinicopathologic Studies on Gestational Trophoblastic Neoplasia, especially Hydatidiform Mole

Hydatidiform mole has been known for its potential for malignant transformation and for its various chromosomal karyotypes. However, the relationship between histologic grading of hydatidiform mole and its future malignant transformation is still controversial. This study was undertaken to determine the cytogentic aspects of gestational trophoblastic neoplasia, especially of hydatidiform mole with respect to its malignant transformation. Cytogenetic studies were performed in 34 cases of hydatidiform mole, 2 cases of invasive mole, and 2 cases of choriocarcinoma. The results were analyzed comparatively using clinical histopathological and endocrinological (human chorionic gonadotropin titer) data. Among the 34 cases of hydatidiform mole studied, 26 cases were complete moles and the remaining 8 were partial moles with karyotypes being diploid (46, XX, 24, 46, XY, 2), and triploid (69, XXY) respectively. Two cases of XX mole among 26 complete hydatidiform moles developed distant metastasis during the follow-ups, suggesting transformation into choriocarcinoma; both cases showed 46, XX in karyotype and Grade III in histologic grading. Not one case of triploid partial hydatidiform mole transformed into malignancy. The karyotypes of the two cases each of invasive mole and choriocarcinoma were from neardiploid to hypotetraploid, and aneuploid cells were predominant in choriocarcinoma.

Chromosome study of partial hydatidiform mole: A case report.

A case of partial hydatidiform mole was admitted with hyperemesis gravidarum, human chorionic gonadotrophine was at high level. Ultrasonographic study showed the empty gestational sac with enlarged placenta which had cystic change in some area. The histologic study showed only hydatidiform mole but chromosome study confirmed classical partial hydatidiform mole which had a triploid (69 XXY) constitution. The clinical findings, ultrasound study and HCG level can emphasize this condition. Histologic and genetic study will confirm the diagnosis.

Partial hydatidiform mole: Report of 1 case.

A case of partial hydatidiform mole admitted with pre-eclampsia delivery of a living baby at 34 weeks was reported. Ultrasonographic study showed foetus with intrauterine growth retardation and cystic change of the placenta. The final diagnosis was made by pathologic histology. We suggested the clinical findings and ultrasonographic findings reminded the physician that some of this foetus has chromosome abnormalities. Correct diagnosis prenatally, will make the opportunity for the physician to manage such cases properly.